The British investment bank Barclays has raised its price target for Schott Pharma DE000A3ENQ51 shares from 26 to 32 euros and upgraded the shares from "Equal Weight" to "Overweight".

Select Language

English

Down Icon

Select Country

Germany

Down Icon

Loading